Letter to the EditorInternational Journal of Research in Dermatology
Publication: Real-world symptom improvement in paediatric atopic dermatitis: insights from patient‑reported outcome measures with mometasone furoate
Int J Res Dermatol. 2026;12(5):536-537.DOI10.18203/issn.2455-4529.IntJResDermatol20262335
Abstract
Patient‑reported outcome measures (PROMs) are validated tools that complement physician assessments and play a crucial role in guiding treatment decisions and monitoring disease burden in atopic dermatitis (AD). However, their use in routine clinical practice stays limited due to low physician awareness and adoption1. Additionally, topical corticosteroid (TCS) phobia among patients and caregivers can adversely affect adherence and treatment outcomes.
Keywords
Affiliations
- Department of Dermatology, Karuna Hospital, Delhi, India
- Department of Paediatrics, Janani Nursing Home, Sambhajinagar, Aurangabad, Gujarat, India
- Department of Global Medical Affairs, Glenmark Pharmaceuticals Ltd, Mumbai, Maharashtra, India